• About Us
  • Corporate Profile
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Respiratory and Acute Care Advisory Board
  • Cardiovascular Advisory Board
  • Immunology Advisory Board
  • Investors
• Products
• Research
  • sPLA2 - What is it?
  • Respiratory and Acute Care Program
  • sPLA2 in SCD
  • IMPACTS Trial Site
  • Scientific Advisory Board
  • Cardiovascular Program
  • sPLA2 in CVD
  • FRANCIS Trial Site
  • PLASMA Trial Site
  • PLASMA 2 Trial Site
  • Scientific Advisory Board
  • Immunology Program
  • A-623 in SLE and Autoimmune Diseases
  • Scientific Advisory Board
  • Preclinical Programs
  • Glossary
  • References
• News & Media
• Careers
• Contact Us

<< Return to Scientific Advisory Board

Scientific Advisory Board: Cardiovascular

Stephen J. Nicholls‚ MBBS‚ PhD‚ FRACP‚ FACC

Stephen J. Nicholls‚ MBBS‚ PhD‚ FRACP‚ FACC is a Director‚ Intravascular Ultrasound Core Laboratory and Associate Director‚ Cardiovascular Coordinating Center at Cleveland Clinic. He received his medical degree at the University of Adelaide and completed his internship and residency at the Royal Adelaide Hospital in Adelaide‚ SA‚ Australia. Dr. Nicholls is a member of several scientific and professional organizations. He is also an ad hoc manuscript reviewer for several major cardiology journals including Circulation. Dr. Nicholls has published over 40 peer-reviewed scientific papers and 71 abstracts.

©2006 Anthera Pharmaceuticals‚ Inc. All Rights Reserved
Legal Disclaimer | Privacy Statement